Counterfeit Medicines Are a Problem in the European Union—A Problem that is Continuing to Grow

According to a report from Europol’s Intellectual Property Crime Threat Assessment 2019, “Counterfeit pharmaceuticals pose a growing threat to the EU, affecting a large number of Member States. A wide and increasingly diverse range of medicines is targeted by counterfeiters.”
The Europol ICP Threat Assessment reports that there has been an increase in seizures of counterfeit drugs used in the treatment of serious illnesses, as well as a growing number of counterfeit drug incidents affecting the legal drug supply chain. 

[...]

New Report Highlights Continued Illicit Online Prescription Drugs Sales In China

ASOP Global and LegitScript released a report analyzing the prevalence of illicit online sales of prescription drugs in China, a country where such sales are prohibited. Their analysis showed that about half of all Chinese online pharmaceuticals sellers are illicit, potentially exposing patients to counterfeit medicines, substandard medicines, financial fraud, and identity theft…

[...]

LA City Attorney Files Charges in 2 Different Counterfeit/Misbranded Prescription Drug Cases

On August 21, LA City Attorney Mike Feuer announced two separate cases had resulted in charges. In the first, criminal charges have been filed against eight people for allegedly importing more than 100,000 units of non-FDA approved pharmaceuticals, and selling them in the local area on the street in front of local businesses. In a second case, Feuer’s office seized a website offering illegal, misbranded, and counterfeit medications for sale online.

[...]